Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant 2011 Feb;17(2):192-6 PMID: 21182973 PMCID: PMC3387575
Pubmed ID
21182973DOI
10.1016/j.bbmt.2010.08.020Author List
Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE, Blood and Marrow Transplant Clinical Trials Network, State of the Science Cell and Gene Therapy CommitteeAuthor
Mary M. Horowitz MD, MS Center Director, Professor in the Medicine department at Medical College of WisconsinScopus
2-s2.0-79251497333 1 CitationsMESH terms used to index this publication - Major topics in bold
Bone Marrow TransplantationClinical Trials, Phase II as Topic
Cord Blood Stem Cell Transplantation
Evidence-Based Medicine
Hematopoietic Stem Cell Transplantation
Humans
Multicenter Studies as Topic
National Cancer Institute (U.S.)
National Heart, Lung, and Blood Institute (U.S.)
Peripheral Blood Stem Cell Transplantation
Research Design
Research Support as Topic
United States
